Fluticasone Propionate and Salmeterol

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 31, 2021
Approval ID: 43a27267-2f2b-410d-9c30-9cb95f35d9a1
Products: 3 registered
Version: 19

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation useInitial U.S. Approval: 2000

Quick Stats

Total Products3

Labelers2

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.